It was also induced by epidermal growth factor receptor (EGFR) inhibitors in non-small-cell lung cancer (NSCLC), resulting in reduced apoptosis [122], while in glioblastoma, either chemotherapy or radiotherapy could upregulate BCL6 expression, which facilitated a blunting of the effectiveness of these therapies [123]. The gene discussed is BCL6; the disease is non-small cell lung carcinoma.